The impact of using different imputation methods for missing quality of life scores on the estimation of the cost-effectiveness of lung-volume-reduction surgery

Health Economics

Volumn 18, Issue 1, 2009, Pages 91-101

  Blough, David K ^a   Ramsey, Scott ^b   Sullivan, Sean D ^a   Yusen, Roger ^c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cost effectiveness analysis; Imputation; Lung volume reduction; Missing data

Indexed keywords

ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; ECONOMIC EVALUATION; EMPHYSEMA; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; LUNG RESECTION; MAJOR CLINICAL STUDY; POST HOC ANALYSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; WELLBEING; ECONOMICS; METHODOLOGY; OUTCOME ASSESSMENT; STATISTICAL MODEL;

COST-BENEFIT ANALYSIS; HUMANS; MODELS, STATISTICAL; OUTCOME ASSESSMENT (HEALTH CARE); PNEUMONECTOMY; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY-ADJUSTED LIFE YEARS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 61449426157     PISSN: 10579230     EISSN: 10991050     Source Type: Journal    
DOI: 10.1002/hec.1347     Document Type: Article

References (23)

1. Bennett P, Britt P, Dwyer D, Hurley T, McCarthy F, O'Callaghan F, O'Caoimh L, Rudden M, van Den Hurk E, Brand J, Tyler D, Roche C. 1999. Solas for Missing Data Analysis 2.0. Statistical Solutions, Ltd.: Cork, Ireland.
2. Briggs A, Clark T, Wolstenholme J, Clarke P. 2003. Missing... presumed at random: cost-analysis of incomplete data. Health Economics 12: 377-392.
3. Diggle PJ, Heagerty PJ, Liang KY, Zeger SL. 2002. Analysis of Longitudinal Data. Oxford University Press: London.
4. Fishman A, Martinez F, Naunheim K, Piantadosi S, Wise R, Ries A, Weinmann G, Wood DE. 2003. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. New England Journal of Medicine 348: 2059-2073.
5. Gould AL. 1980. A new approach to the analysis of clinical drug trials with withdrawals. Biometrics 36: 721-727.
6. Horton NJ, Lipsitz SR. 2001. Multiple imputation in practice: comparison of software packages for regression models with missing variables. The American Statistician 55: 244-254.
7. Kaplan RM. 1997. Decisions about prostate cancer screening in managed care. Current Opinion in Oncology 9: 480-486.
8. Lin DY, Feuer EJ, Etzioni R, Wax Y. 1997. Estimating medical costs from incomplete follow-up data. Biometrics 53: 419-434.
9. Lin TH. 2006. Missing data imputation in quality-of-life assessment: imputation for WHOQOL-BREF. Pharmacoeconomics 24: 917-925.
10. Little RJA, Rubin DB. 1987. Statistical Analysis with Missing Data. Wiley: NY.
11. Lothgren M, Zethraeus N. 2000. Definition, interpretation and calculation of cost-effectiveness acceptability curves. Health Economics 9: 623-630.
12. National Emphysema Treatment Trial Research Group. 2001. Patients at high risk of death after lung-volume-reduction surgery. New England Journal of Medicine 345: 1075-1083.
13. Oostenbrink JB, Al MJ, Rutten-van Molken MP. 2003. Methods to analyse cost data of patients who withdraw in a clinical trial setting. Pharmacoeconomics 21: 1103-1112.
14. Oostenbrink JB, Al MJ. 2005. The analysis of incomplete cost data due to dropout. Health Economics 14: 763-776.
15. Piantadosi S. 1997. Clinical Trials: A Methodologic Perspective. Wiley: NY.
16. Ramsey S, Willke R, Briggs A, Brown R, Buxton M, Chawla A, Cook J, Glick H, Liljas B, Petitti D, Reed S. 2005. Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA Task Force report. Value in Health 8: 521-533.
17. Ramsey SD, Berry K, Etzioni R, Kaplan RM, Sullivan SD, Wood DE. 2003. Cost effectiveness of lung-volume-reduction surgery for patients with severe emphysema. New England Journal of Medicine 348: 2092-2102.
18. Rubin DB. 1996. Multiple imputation after 18+ years. Journal of the American Statistical Association 91: 473-489.
19. Rubin DB, Schenker N. 1981. Multiple imputation for interval estimation from simple random samples with ignorable nonresponse. Journal of the American Statistical Association 81: 366-374.
20. Rutten-van Molken MP, van Doorslaer EK, van Vliet RC. 1994. Statistical analysis of cost outcomes in a randomized controlled clinical trial. Health Economics 3: 333-345.
21. SAS Institute Inc. 2005. SAS Version 9.1. SAS Institute Inc.: Cary, NC, MI procedure.
22. Schafer JL. 1997. Analysis of Incomplete Multivariate Data. Chapman & Hall: London.
23. Schimert J, Schafer JL, Hesterberg T, Fraley C, Clarkson DB. 2001. Analyzing Data with Missing Values in S-Plus. Insightful Corporation: Seattle, WA.